Knockout ACAA2 homolog MTP reduced fatty acid oxidation capacity in the liver, and increased hepatic steatosis and the expression of inflammatory marker CD68, accelerating the progression of NAFLD12. Here, CD68 is linked to Hepatic steatosis.